Aarhus
Aarhus
Aarhus, Aarhus N, Denmark11 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Thrombolysis in Factor Xa-inhibitors Trial | Acute Ischemic Stroke, Hemorrhage, Intracranial Hemorrhages, Pathologic Processes, Pathological Conditions, Signs and Symptoms, brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, ischemic stroke, nervous system disorder, stroke disorder, vascular disorder | Recruiting | Phase 3 | 2026-09-23 | NCT06878066 | |
| The mHTX APP Program | Follow up; Rehabilitation | Enrolling by invitation | Not applicable | 2026-09-10 | NCT07813416 | |
| Automated Insulin Delivery Versus Usual Insulin Treatment Modality Before and During Pregnancy in Women With Type 1 Diabetes | Female Urogenital Diseases and Pregnancy Complications, Urogenital Diseases, pregnancy disorder | Recruiting | Not applicable | 2026-08-12 | NCT07240012 | |
| Efficacy of Solifenacin, Mirabegron and Combination Therapy in Children With Daytime Urinary Incontinence (BeDry) | Diurnal Enuresis, Elimination Disorders, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Lower Urinary Tract Symptoms, Male Urogenital Diseases, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Urinary Incontinence, Urination Disorders, Urogenital Diseases, Urological Manifestations, enuresis, overactive bladder, psychiatric disorder, urinary bladder disorder, urinary system disorder | Recruiting | Phase 3 | 2026-06-08 | NCT06551246 | |
| Strategy for Withdrawal of Pharmacological Treatment for Urinary Incontinence in Children (StayDry) | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Lower Urinary Tract Symptoms, Male Urogenital Diseases, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Urinary Incontinence, Urination Disorders, Urogenital Diseases, Urological Manifestations, urinary system disorder | Active, not recruiting | Phase 4 | 2026-06-08 | NCT06465576 | |
| An Open Label Clinical Study to Evaluate Tanruprubart (Also Commonly Known as ANX005) in Participants With Guillain-Barré Syndrome (FORWARD Study) | Chronic Disease, Disease Attributes, Guillain-Barre syndrome, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Post-Infectious Disorders, autoimmune disease, autoimmune disorder of the nervous system, demyelinating disease, immune system disorder, nervous system disorder, neuromuscular disease, peripheral nervous system disorder, polyneuropathy, polyradiculoneuropathy | Recruiting | Phase 3 | 2026-05-28 | NCT07020819 | |
| NORTH-REG Dwell-Time Study | Side Effect of Drug | Active, not recruiting | Phase 4 | 2026-03-03 | NCT04701151 | |
| Gene Therapy for Wilson Disease Evaluated by 64Cu PET/CT | Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Digestive System Diseases, Nutritional and Metabolic Diseases, Wilson disease, basal ganglia disorder, brain disorder, central nervous system disorder, hereditary disease, inborn errors of metabolism, inborn metal metabolism disorder, inherited neurodegenerative disorder, liver disorder, metabolic disease, movement disorder, nervous system disorder, neurodegenerative disease | Enrolling by invitation | Not stated | 2025-09-08 | NCT07159581 | |
| Long Term Effects of Oral Versus Transdermal Estrogen Replacement Therapy in Turner Syndrome | Cardiovascular Abnormalities, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Sex Chromosome Disorders, Turner syndrome, Urogenital Abnormalities, Urogenital Diseases, cardiovascular disorder, chromosomal disorder, congenital heart disease, disorder of sexual differentiation, endocrine system disorder, gonadal disorder, gonadal dysgenesis, heart disorder, hereditary disease, hypogonadism, sex chromosome disorder of sex development | Recruiting | Phase 4 | 2024-08-26 | NCT06570460 | |
| Determining Dose Equivalence Between Oral and Transdermal Estrogen Treatment in Women With Turner Syndrome | Cardiovascular Abnormalities, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Sex Chromosome Disorders, Turner syndrome, Urogenital Abnormalities, Urogenital Diseases, cardiovascular disorder, chromosomal disorder, congenital heart disease, disorder of sexual differentiation, endocrine system disorder, gonadal disorder, gonadal dysgenesis, heart disorder, hereditary disease, hypogonadism, sex chromosome disorder of sex development | Recruiting | Phase 4 | 2024-08-23 | NCT06544473 | |
| Myocardial Perfusion Imaging by 15O-H2O PET/CT | Arterial Occlusive Diseases, arteriosclerosis disorder, cardiovascular disorder, coronary artery disorder, heart disorder, myocardial ischemia, vascular disorder | Recruiting | Not stated | 2024-01-24 | NCT04451551 |